RNTX$0.6664+4.88%
Rein Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$57.49M
Float & O/S:
Inst Own:
DilutionScan read 26 of Rein Therapeutics, Inc.'s SEC filings and found 7 warrant series, 4 convertibles, 3 ATM programs, 1 equity line, 3 shelf registrations, 2 S-1 registrations and 4 completed offerings on file for RNTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 7, 2026.
